Pathfinder Presents Preliminary Data on New Regenerative Approach to Diabetes Treatment
February 21, 2012 08:01 ET
|
Pathfinder Cell Therapy, Inc.
CAMBRIDGE, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diabetes and other...
Pathfinder to Present at New York Stem Cell Summit
February 16, 2012 08:00 ET
|
Pathfinder Cell Therapy, Inc.
CAMBRIDGE, Mass., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
Pathfinder Announces First European Patent Allowance for Pathfinder Cells
February 15, 2012 08:00 ET
|
Pathfinder Cell Therapy, Inc.
CAMBRIDGE, Mass., Feb. 15, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
Pathfinder Cell Therapy Provides Update on Pathfinder Cell Research and Development
December 13, 2011 10:00 ET
|
Pathfinder Cell Therapy, Inc.
CAMBRIDGE, Mass., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases characterized by...